1.51 USD
-0.09 (-5.63%)
Last: Jan 30, 2026, 08:21 PM
Taking everything into account, TLSA scores 0 out of 10 in our fundamental rating. TLSA was compared to 525 industry peers in the Biotechnology industry. TLSA has a bad profitability rating. Also its financial health evaluation is rather negative. TLSA is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past 5 years TLSA always reported negative net income.
- In the past 5 years TLSA always reported negative operating cash flow.
1.2 Ratios
- The profitability ratios for TLSA are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TLSA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- TLSA has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for TLSA has been increased compared to 5 years ago.
- The debt/assets ratio for TLSA has been reduced compared to a year ago.
2.2 Solvency
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- TLSA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TIZIANA LIFE SCIENCES LTD / TLSA FAQ
What is the fundamental rating for TLSA stock?
ChartMill assigns a fundamental rating of 0 / 10 to TLSA.
Can you provide the valuation status for TIZIANA LIFE SCIENCES LTD?
ChartMill assigns a valuation rating of 0 / 10 to TIZIANA LIFE SCIENCES LTD (TLSA). This can be considered as Overvalued.
What is the profitability of TLSA stock?
TIZIANA LIFE SCIENCES LTD (TLSA) has a profitability rating of 0 / 10.
What is the financial health of TIZIANA LIFE SCIENCES LTD (TLSA) stock?
The financial health rating of TIZIANA LIFE SCIENCES LTD (TLSA) is 0 / 10.